| 新型肌松药拮抗剂sugammadex(Org 25969)临床研究进展 |
| |
| 引用本文： | 周桥灵,杨承祥.新型肌松药拮抗剂sugammadex(Org 25969)临床研究进展[J].国际麻醉学与复苏杂志,2009,30(2). |
| |
| 作者姓名： | 周桥灵 杨承祥 |
| |
| 作者单位： | 1. 徐州医学院江苏省麻醉医学研究所&江苏省麻醉学重点实验室,221002
2. 221002,徐州医学院江苏省麻醉医学研究所&江苏省麻醉学重点实验室;中山大学附属佛山医院麻醉科 |
| |
| 摘 要： | 此文综述sugammade近年来的临床研究概况.文章认为sugammadex可安全有效拮抗罗库溴铵的肌松效应,其效能呈剂量依赖性.同时也可安全有效拮抗未成年人、老年人或心脏病患者、肺病患者和肾衰患者罗库溴铵的肌松效应,副作用少.与传统肌松拮抗药比较,sugammadex具有显著优势,有广泛应用前景.
|
| 关 键 词： | 肌松药拮抗剂 罗库溴铵 |
Progress in clinical research of selective relaxant antognist,sugammadex |
| |
| ZHOU Qiao-ling,YANG Cheng-xiang.Progress in clinical research of selective relaxant antognist,sugammadex[J].international journal of anesthesiology and resuscitation,2009,30(2). |
| |
| Authors: | ZHOU Qiao-ling YANG Cheng-xiang |
| |
| Abstract: | Sugammadex can safely and effectively antagonize rocuronium -induced neuromuscular blockade,in a dose-de-pendent manner,including the cases with pulmonary and cardiac diseases.The clinical use of sugammadex promises to elimi-nate many of the shortcomings in our current practice with regard to the antagonism of roeuronium and possibly other steroidal neuromuscular blockers. |
| |
| Keywords: | Sugammadex |
| 本文献已被 万方数据 等数据库收录！ |
|
